Trial site
Mautalen Salud e Investigación
- 22running trials
- 13closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes14 trials
- Obesity12 trials
- Migraine4 trials
- Chronic kidney disease3 trials
- Heart failure3 trials
- Type 1 diabetes3 trials
- Asthma2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Stroke2 trials
- Ulcerative colitis2 trials
- Alzheimer disease1 trial
- Bipolar disorder1 trial
- and 5 more
- Phase
- Phase 326 trials
- Phase 29 trials
- Status
- Completed12 trials
- Active, not recruiting10 trials
- Not yet recruiting6 trials
- Recruiting6 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company27 trials
- H. Lundbeck A/S3 trials
- Boehringer Ingelheim2 trials
- Incyte Corporation1 trial
- Pfizer1 trial
- and 1 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Not yet recruiting
Recruiting
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Recruiting
Active, not recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity5 recruiting
- Type 2 diabetes4 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Bipolar disorder1 recruiting
- Bronchiectasis1 recruiting
- Chronic kidney disease1 recruiting
- High blood pressure1 recruiting
- Migraine1 recruiting
- Stroke1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Completed
Terminated
Completed
Completed
Completed
Recruiting
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 18 Nov 2026